Royce & Associates’s Veracyte VCYT Stock Holding History

Royce & Associates’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-40,150	Closed	-$1.3M	–	1042
2020 Q3	$1.3M	Hold	40,150	–	–	0.01%	745
2020 Q2	$1.04M	Sell	40,150 -51,000	-56%	-$1.27M	0.01%	774
2020 Q1	$2.22M	Hold	91,150	–	–	0.03%	566
2019 Q4	$2.54M	Sell	91,150 -56,000	-38%	-$1.45M	0.02%	652
2019 Q3	$3.53M	Sell	147,150 -25,000	-15%	-$665K	0.03%	569
2019 Q2	$4.91M	Sell	172,150 -75,000	-30%	-$1.87M	0.04%	495
2019 Q1	$6.18M	Hold	247,150	–	–	0.05%	452
2018 Q4	$3.11M	Hold	247,150	–	–	0.03%	609
2018 Q3	$2.36M	Buy	247,150 +172,150	+230%	+$1.9M	0.02%	797
2018 Q2	$701K	Buy	+75,000	New	+$527K	﹤0.01%	990
2016 Q4	–	Sell	-27,000	Closed	-$205K	–	1108
2016 Q3	$205K	Hold	27,000	–	–	﹤0.01%	1043
2016 Q2	$136K	Buy	+27,000	New	+$145K	﹤0.01%	1056

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Royce & Associates's VCYT Position: Q4 2020 in Review

Royce & Associates sold out of Veracyte (VCYT) in Q4 2020, closing a stake of 40,150 shares — an estimated $1.3M sold.

Royce & Associates first reported a position in VCYT in Q2 2016 and held it in 12 quarters. The position peaked at $6.18M in Q1 2019. 222 funds tracked by Wall St. Rank hold VCYT as of Q4 2020.

Royce & Associates reported no remaining Veracyte position as of Q4 2020 after selling out during the quarter.
Royce & Associates sold 40,150 Veracyte shares in Q4 2020, an estimated $1.3M.
Royce & Associates first reported a position in Veracyte in Q2 2016 and held it in 12 quarters.
Royce & Associates's Veracyte position peaked at $6.18M in Q1 2019.
222 funds tracked by Wall St. Rank held Veracyte as of Q4 2020.

Based on Royce & Associates's 13F filing for Q4 2020, filed 8 Feb 2021.